葡萄糖皮质类药物的临床价值对于严重的社区获得性肺炎:基于随机对照试验的系统审查和元分析
Biao Peng1, Jin Li2, Minwei Chen3
1Department of Respiratory and Critical Care Medicine, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China.
葡萄糖皮质类药物缩短了严重的社区获得性肺炎 (sCAP) 患者的机械通风和血管活性药物使用. 这项研究没有发现不良事件的风险增加,这表明它们对特定sCAP病例的益处.
科学领域:
- 肺部病理学 肺部病理学
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的社区获得性肺炎 (sCAP) 具有显著的死亡风险,而葡萄糖皮质激素的使用是有争议的治疗选择.
- 新型冠状病毒的近期影响加剧了澄清sCAP治疗方案的需要.
- 这项研究旨在评估葡萄糖皮质类药物在sCAP管理中的临床疗效和安全性.
结论:
- 在sCAP患者中,葡萄糖皮质类药物有效减少机械通风和血管活性药物需求.
- 用葡萄糖皮质体治疗并没有增加死亡,胃肠道出血或多种感染的风险.
- 对于出现呼吸衰竭或血液动力学不稳定的sCAP患者,可能会建议使用葡萄糖皮质类药物.
更多相关视频
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pneumonia II: Pathophysiology
